Production (Stage)
HCW Biologics Inc.
HCWB
$5.22
-$0.27-4.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.75M | -30.02M | -37.33M | -38.37M | -27.39M |
| Total Depreciation and Amortization | 1.36M | 1.18M | 776.40K | 925.50K | 1.08M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.19M | 1.01M | 6.23M | 6.17M | 6.09M |
| Change in Net Operating Assets | 8.07M | 13.60M | 15.04M | 13.32M | -2.25M |
| Cash from Operations | -14.14M | -14.23M | -15.29M | -17.95M | -22.48M |
| Capital Expenditure | -131.90K | -261.60K | -3.86M | -4.46M | -6.03M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 10.00M | 10.00M |
| Cash from Investing | -131.90K | -261.60K | -3.86M | 5.54M | 3.97M |
| Total Debt Issued | 5.16M | 6.91M | 6.53M | 3.70M | 1.75M |
| Total Debt Repaid | -122.20K | -119.40K | -117.70K | -97.10K | -68.00K |
| Issuance of Common Stock | 6.92M | 9.42M | 2.52M | 2.52M | 2.52M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -660.30K | -638.00K | -- | -- | -- |
| Cash from Financing | 11.29M | 15.57M | 8.93M | 6.12M | 4.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.98M | 1.08M | -10.22M | -6.29M | -14.31M |